Prescription Opioid Abuse and Tampering in the United States: Results of a Self-Report Survey

被引:24
作者
Vietri, Jeffrey [1 ]
Joshi, Ashish V. [2 ]
Barsdorf, Alexandra I. [3 ]
Mardekian, Jack [2 ]
机构
[1] Kantar Hlth, I-20121 Milan, MI, Italy
[2] Shire Dev LLC, New York, NY USA
[3] Pfizer, New York, NY USA
关键词
Abuse; Opioids; Substance Abuse; WORK PRODUCTIVITY; NONMEDICAL USE; PAIN; COSTS; MISUSE;
D O I
10.1111/pme.12475
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
ObjectiveThe objective of this study is to estimate the prevalence and impact of prescription opioid abuse and tampering among US adults. MethodsParticipants from the US National Health and Wellness Survey were invited to complete an online survey assessing use, misuse, and abuse of prescription opioid medications in the preceding 3 months. A total of 25,864 adults were screened for self-reported opioid abuse. Prevalence was calculated using weights based on age, gender, race, and education. Respondents reporting abuse or medical use of prescription opioid medication in the prior 3 months (N=1,242) completed a questionnaire assessing health care resource use and the Work Productivity and Activity Impairment questionnaire. ResultsThe prevalence of prescription opioid abuse in the 3 months prior to the survey was estimated at 1.31% of US adults, with approximately half (0.67%) tampering during that time. Opioid abuse increased with younger age, male sex, minority race, psychiatric illness, alcoholism, cigarette smoking, being employed, and higher household income. Respondents abusing opioid medications reported greater impairment in work and nonwork activities and more health care use than nonusers. Tampering with opioid medication was associated with greater productivity loss and increased use of health care (all P<0.05). ConclusionsTampering with opioid medications to get high is associated with substantial loss of productivity and health care use. Technologies that reduce users' ability to tamper may reduce the burden of opioid abuse on the health care system.
引用
收藏
页码:2064 / 2074
页数:11
相关论文
共 30 条
[1]  
[Anonymous], 2013, NSDUH SERIES H 46 HH
[2]  
Atluri Sairam, 2003, Pain Physician, V6, P233
[3]   Gender and prescription opioids: Findings from the National Survey on Drug Use and Health [J].
Back, Sudie E. ;
Payne, Rebecca L. ;
Simpson, Annie N. ;
Brady, Kathleen T. .
ADDICTIVE BEHAVIORS, 2010, 35 (11) :1001-1007
[4]   Opioid extended-release tablets with improved tamper-resistant properties [J].
Bartholomaeus, Johannes H. ;
Arkenau-Maric, Elisabeth ;
Galia, Eric .
EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (08) :879-891
[5]   Estimated costs of prescription opioid analgesic abuse in the United States in 2001 - A societal perspective [J].
Birnbaum, Howard G. ;
White, Alan G. ;
Reynolds, Jennifer L. ;
Greenberg, Paul E. ;
Zhang, Mingliang ;
Vallow, Sue ;
Schein, Jeff R. ;
Katz, Nathaniel P. .
CLINICAL JOURNAL OF PAIN, 2006, 22 (08) :667-676
[6]   Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States [J].
Birnbaum, Howard G. ;
White, Alan G. ;
Schiller, Matt ;
Waldman, Tracy ;
Cleveland, Jody M. ;
Roland, Carl L. .
PAIN MEDICINE, 2011, 12 (04) :657-667
[7]   Association of insomnia with quality of life, work productivity, and activity impairment [J].
Bolge, Susan C. ;
Doan, Justin F. ;
Kannan, Hema ;
Baran, Robert W. .
QUALITY OF LIFE RESEARCH, 2009, 18 (04) :415-422
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   Opioid analgesics - Comparative features and prescribing guidelines [J].
Cherny, NI .
DRUGS, 1996, 51 (05) :713-737
[10]  
DiBonaventura Marco DaCosta, 2010, J Med Econ, V13, P709, DOI 10.3111/13696998.2010.535576